Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep368 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Graft vs host disease and insulin resistance after bone marrow transplantation

Athanassiou Panagiotis , Kostoglou-Athanassiou Ifigenia

Graft vs host disease is a disorder in which the graft, i.e. bone marrow, attacks the host after bone marrow transplantation. It has various manifestations, one being skin and muscle involvement with cutaneous sclerosis and diffuse muscle pain. The aim was to describe the case of a patient with graft vs host disease complicated by insulin resistance and metabolic syndrome, after bone marrow transplantation for the treatment of acute lymphoblastic leukemia.<p class="abstext...

ea0049ep222 | Bone &amp; Osteoporosis | ECE2017

Is osteoporosis a curable disease?

Kostoglou-Athanassiou Ifigenia , Pantazi Eleni , Athanassiou Panagiotis

Osteoporosis may be a disease of unknown etiology, or a degenerative disorder in the context of aging. Nowadays, the availability of multiple forms of effective drug treatment for osteoporosis have raised the hypothesis that osteoporosis may be not only a treatable but moreover a curable disease.The aim was to describe the case of a patient with osteoporosis who after treatment with alendronate for 6 years had osteopenia and remains in the state of osteo...

ea0049ep1300 | Thyroid (non-cancer) | ECE2017

Primary hyperparathyroidism coexisting with Graves’ disease in a patient with vitamin D deficiency

Athanassiou Panagiotis , Kostoglou-Athanassiou Ifigenia , Pantazi Eleni

Primary hyperparathyroidism is known to coexist with thyroid cancer and breast cancer. However, primary hyperparathyroidism coexisting with Graves’ disease is extremely rare. The aim was to describe the case of a patient with Graves’ disease causing severe hyperthyroidism who in the course of the disease developed vitamin D deficiency and primary hyperparathyroidism. A patient, female, aged 49 years, presented with severe hyperthyroidism causing tachycardia, palpitat...

ea0049ep136 | Clinical case reports - Pituitary/Adrenal | ECE2017

Adrenal carcinoma after ovariectomy. Report of a case

Xanthakou Eleni , Spyropoulos Panagiotis , Athanassiou Panagiotis , Kostoglou-Athanassiou Ifigenia

Adrenocortical tumorigenesis has been observed in mice. It is speculated to be gonadotropin dependent. In particular LH receptors appear to be found within such adrenal tumors in high density and elevated LH levels may be related to adrenal tumorigenesis. The aim was to describe the case of a patient who after ovariectomy developed a large malignant adrenal tumor. A patient, female, aged 42 presented with uterine leiomyomas. She was treated by surgical excision of the uterus a...

ea0041ep1153 | Thyroid cancer | ECE2016

Thyroid cancer in a patient with neurofibromatosis type 1: von recklinghausen disease

Karaitianos Ioannis , Athanassiou Panagiotis , Tsomidou Christiana , Kostoglou-Athanassiou Ifigenia

Introduction: Neurofibromatosis type 1 or von Recklinghausen disease is a systemic hereditary disease characterized by disorders regarding the skin, neural and skeletal systems. Osteoporosis is one of the skeletal manifestations of neurofibromatosis type 1, being associated with increased fracture risk. Neurofibromatosis type 1 is associated with a propensity for the development of cancer, breast cancer in particular being associated with neurofibromatosis type 1.<p class=...

ea0035p96 | Bone and Osteoporosis | ECE2014

Jaw osteonecrosis in a patient with postmenopausal osteoporosis on antiresorptive treatment

Kostoglou-Athanassiou Ifigenia , Athanassiou Panagiotis , Xanthakou Eleni , Kaldrymides Philippos

: Postmenopausal osteoporosis is a common condition affecting many women. Management of postmenopausal osteoporosis involves the administration of vitamin D, calcium and antiresorptive agents. The long-term management of postmenopausal osteoporosis with antiresorptive agents may present some dangers and adverse effects such as bone necrosis or atypical bone fractures.Case report: The aim was to describe the case of a female patient with postmenopausal ...

ea0035p396 | Diabetes (epidemiology, pathophysiology) | ECE2014

Vitamin D and diabetes mellitus type 2

Kostoglou-Athanassiou Ifigenia , Athanassiou Panagiotis , Gkountouvas Anastasios , Kaldrymides Philippos

Vitamin D deficiency has been observed in diabetes mellitus type 2 patients. It has been found to be related to poor glycemic control in diabetes mellitus type 2 patients as well as in patients with gestational diabetes. The administration of vitamin D in diabetes mellitus type 2 patients with vitamin D deficiency has been found to have conflicting results on blood glucose control. The aim was to assess the effect of vitamin D administration in diabetes mellitus type 2 patient...

ea0011p171 | Clinical case reports | ECE2006

Polymyalgia rheumatica and Hashimoto thyroiditis

Karachalios GN , Kostoglou-Athanassiou I , Athanassiou P , Kaldrymidis Ph

Polymyalgia rheumatica is a chronic autoimmune inflammatory rheumatic disorder of unknown aetiology. Hashimoto thyroiditis is an autoimmune thyroid disorder characterised by the presence of antithyroid antibodies. Hashimoto thyroiditis has been described in patients with systemic autoimmune disorders such as systemic lupus erythematosus. The aim of the study was to describe the case of a patient who had polymyalgia rheumatica and developed Hashimoto thyroiditis.<p class="a...

ea0011p436 | Endocrine disruptors | ECE2006

Loss and resumtion of ovarian function after mitotane administration

Kostoglou-Athanassiou I , Goula M , Athanassiou P , Kaldrymidis Ph

The adrenolytic agent mitotane [o,p’-DDD or 1,1-(o,p’-dichlorodiphenyl)-2,2-dichloroethane] is a derivative of the insecticide DDT and is used for the treatment of adrenal carcinoma. It induces necrosis and atrophy of the adrenal cortex. Estrogenic action after single exposure but intense antiestrogenic action after repeated exposure of porcine ovarian follicles has been observed in vitro (Wojtowicz et al. 2004).The aim of the stu...

ea0056p106 | Clinical case reports - Pituitary/Adrenal | ECE2018

Cushing’s syndrome in a patient with systemic lupus erythematosus

Kostoglou-Athanassiou Ifigenia , Spiliotis George , Athanassiou Lambros , Myriokefalitakis Ioannis

Introduction: Systemic lupus erythematosus is a systemic autoimmune disease, which often necessitates the administration of corticosteroids for its treatment. Cushing’s syndrome is a disorder characterized by the endogenous hypersecretion of cortisol.Aim: The aim was to describe the case of a patient who had systemic lupus erythematosus, was on therapy with corticosteroids and developed Cushing’s syndrome.Case description...